Lupus Clinical Trial
Official title:
Clarifying Misbeliefs About Hydroxychloroquine (HCQ): Developing an Individualized Decision Aid for Diverse Patients With Lupus (HCQ-IDEAL)
The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence. Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.
This study will be no different from a routine lupus or lupus nephritis clinic visit. During the same visit that a participant routinely does for lupus with their healthcare team, a healthcare team member will discuss the tool that elaborates the benefits vs. risks of lupus medications such as hydroxychloroquine. Participants will complete questionnaires that assesses their understanding of the medication (hydroxychloroquine) before and after they complete the discussion regarding the medication using the tool with the healthcare team member. Study team members will study the data collected to answer research questions. They will analyze the data and plan better steps improve care quality in lupus. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013995 -
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
|
Phase 1 | |
| Recruiting |
NCT03952624 -
Patient-Centered Assessment of Symptoms and Outcomes
|
||
| Terminated |
NCT01389895 -
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00710021 -
Vitamin D3 in Systemic Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT02265744 -
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
|
Phase 2 | |
| Completed |
NCT00581763 -
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
|
N/A | |
| Recruiting |
NCT01172002 -
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
|
N/A | |
| Completed |
NCT00299819 -
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
| Completed |
NCT00054938 -
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
|
Phase 2 | |
| Terminated |
NCT03953690 -
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
|
||
| Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
| Enrolling by invitation |
NCT05321108 -
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus
|
N/A | |
| Completed |
NCT00482989 -
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
| Completed |
NCT00657189 -
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
|
Phase 2 | |
| Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
| Completed |
NCT03402087 -
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
|
Phase 1 | |
| Completed |
NCT02857452 -
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
|
N/A | |
| Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
| Completed |
NCT03093402 -
JBT-101 in Systemic Lupus Erythematosus (SLE)
|
Phase 2 | |
| Recruiting |
NCT05018858 -
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus
|
Phase 1 |